Genetic Testing
What can genetic testing tell you about your risk of developing hereditary cancers?
Only about 10% of cancers are due to genetic changes ("variants" or "mutations") that are passed from generation to generation. Knowing your genetic risk for developing cancers can allow your doctor to adjust your screening plan and personalize your treatment options.
Benefits of Genetic Testing for Inherited Cancer Predisposition Syndromes
Genetic testing can have benefits regardless of whether the person receives a positive or negative result.
An informative negative result can provide a person with peace of mind that they have not inherited a harmful gene variant.
For people who already have a cancer diagnosis, the results of genetic tests may help make decisions about their treatment and understand their risk for other cancers.
A positive result gives a person the opportunity to understand and, in some cases, treat their cancer risks.
Genetic testing provides an opportunity for family members to learn about their own cancer risks.
Caris Molecular Intelligence ® Tumor Profiling
The genetic laboratory Caris Life Science offers a new era of personalized cancer treatments with its product ofCaris Molecular Intelligence® Tumor Profiling ( Caris MI) which is a genetic test to choose the best treatment option for the cancer patient. In addition, it gives the opportunity to the patient, if he is a candidate, to be included in clinical studies that are being carried out at the moment.
Caris Molecular Intelligence® is the first and largest tumor profiling service that combines comprehensive analytical testing with research or clinical data on biomarkers to assist clinicians in evaluating potential drug or clinical trial options._cc781905-5cde- 3194-bb3b-136bad5cf58d_
A Caris Molecular Intelligence® report is generated for each patient that can help your doctor customize cancer treatment specific to your cancer or tumor.
We offer you, as part of the service, counseling with a genetic oncologist to review your patient's results.
Endopredict®
Help to make treatment decisions with a high level of confidence.Endopredict®.
After being diagnosed with breast cancer, it can be difficult to understand all of your options available tests and treatments. With the first biopsy, the amount of protein produced by different genes.
Prolaris®
The Myriad Genetics Prolaris® test that stratifies prostate cancer patients according to the aggressiveness of the disease.
Prolaris®distinguishes between aggressive and indolent tumors more accurately than current clinical and pathologic features, allowing clinicians to confidently design optimal treatment strategies for each patient.
Kailos®
The Genetic Panel for Hereditary Cancer that includes verification of 33 genetic variants, the test can be obtained in blood, saliva or mucous membranes. A genetic test can look at changes in these genes that lead to an increased risk of developing hereditary cancers. These types of cancer include breast, ovarian, pancreatic, colorectal, prostate, stomach, skin, uterus, kidney, and others.
Myriad myRisk ®
The myRisk Hereditary Cancer Genetic Panel with 35 genetic variants. This panel is from Myriad Genetics which was the Genetics lab that first isolated the BRCA gene. It has very extensive validation.
Myriad myRisk is a multigene cancer panel test. Multiple gene testing helps avoid missing a potential cancer-causing mutation. Myriad myRisk is the only hereditary cancer test that combines your genetic information with personal and family history, giving your doctor detailed information about your risk to generate management options to help reduce your cancer risks.